Michael O’Rourke CEO to present the ISER Biennial International Society for Eye Research – Belfast UK 13th September 2018 – Ocular Drug Delivery session : The Development and Commercialisation of Sustained Release Ocular Drug Delivery Systems. Dr Raj Thakur, Co...
News
Dr Thakur RR Singh – will be holding Ocular Drug Delivery (OcDD) focus group at the Controlled Release Society, New York, USA, July 21-24th 2018.
Dr Thakur RR Singh – will be holding Ocular Drug Delivery (OcDD) focus group at the Controlled Release Society, New York, USA, July 21-24th 2018.
Michael O’Rourke to deliver key note lecture at world drug delivery summit – New Orleans 2nd-3rd July 2018
Michael O’Rourke CEO Re-Vana Therapeutics will deliver the key note lecture at the world drug delivery summit – New Orleans 2nd-3rd July 2018: “The Development and Commercialisation of Ocular Drug Delivery Systems”
Re-Vana presented at 4th Annual Formulation & Drug Delivery Congress, May 8th-9th 2018.
Re-Vana presented at the 4th Annual Formulation & Drug Delivery Congress – London, UK, May 8th-9th 2018.
Dr. Thakur RR Singh presented at 9th Global Drug Delivery & Formulation Summit, Berlin, Germany
Dr Thakur RR Singh – CSO presented at the 9th Global Drug Delivery & Formulation Summit – Berlin, Germany, March 12th-14th 2018. "Leading device engineers and scientists shared their stories to a packed out room. They covered topics such as risk management, human...
Michael O’Rourke will attend 36th JP Morgan Healthcare Conference
Thirty five years ago, we launched Wall Street's premier investor conference focused exclusively on companies defining the healthcare industry. Today, the J.P. Morgan Healthcare Conference continues our tradition of hosting the largest and most informative healthcare...
Michael O’Rourke presents Re-Vana Therapeutics at Ophthalmic Innovation Summit 2017
Michael O’Rourke presents Re-Vana Therapeutics – ‘Companies to Watch’ at the Ophthalmic Innovation Summit 2017. https://ois.net/companies-watch-re-vana-therapeutics//
Re-Vana Therapeutics agree research collaboration with Nicox
Re-Vana Therapeutics agree research collaboration with Nicox. http://www.nicox.com/assets/files/Nicox-ReVana-Press-Release-_EN_FINAL.pdf
Michael J. O’Rourke, CEO, presented at the Ophthalmology Future Forum 2017
Michael J. O’Rourke, CEO, presented Re-Vana Therapeutics at the Ophthalmology Future Forum 2017, Thursday 05 October, Myriad Crystal Center, Lisbon, Portugal.
Re-Vana to attend events in August and October 2017
Re-Vana will attend the retina and drug delivery focused OIS in Boston, 12th August 2017 and the Ophthalmology Futures Meeting in Lisbon, Portugal 5th October 2017.
Michael O’Rourke interviewed on Re-Vana technology for the Syndicate Room
Watch CEO Michael O’Rourke being interviewed on Re-Vana technology for the Syndicate Room, London, June 22nd 2017. https://www.youtube.com/watch?v=rQ1sjcUAOhg
Re-Vana attended the Ophthalmic Innovation Summit (OIS) Meeting in Los Angeles and ARVO in Baltimore, Maryland, May 2017.
Re-Vana attended the Ophthalmic Innovation Summit (OIS) Meeting in Los Angeles and ARVO in Baltimore, Maryland, May 2017.